Access cutting-edge monoclonal gammopathy of undetermined significance (mgus) treatment through this clinical trial at a research site in Kalamazoo. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Kalamazoo location
Preparing your pre-screening questions…
Access monoclonal gammopathy of undetermined significance (mgus) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related monoclonal gammopathy of undetermined significance (mgus) treatment provided free
Check if you qualify for this monoclonal gammopathy of undetermined significance (mgus) clinical trial in Kalamazoo, MI
No-Cost Study Care
Local to Kalamazoo
Convenient for MI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Blood cancers occur when the molecules that control normal cell growth are damaged. Many of these changes can be detected by directly examining parts of the cancer or cells in blood. Several alterations that occur repeatedly in certain types of blood cancers have already been identified, and these discoveries have led to the development of new drugs that target those alterations. More remain to be discovered. Some of these abnormalities include alterations in genes. Genes are the part of cells that contain the instructions which tell the investigators bodies how to grow and work, and determine physical characteristics such as hair and eye color. Genes are composed of DNA letters that spell out these instructions. Studies of the DNA molecules that make up the genes are called "molecular" analyses. Molecular analyses are ways of reading the DNA letters to identify errors in genes that may contribute to an increased risk of cancer or to the behavior of the cancer cells. Some changes in genes occur only in cancer cells. Others occur in the genes that are passed from parent to child. This research study will examine both kinds of genes. The best way to find these genes is to study large numbers of people. The investigators expect that as many 1000 individuals will enroll in this study. This research study is trying to help doctors and scientists understand why cancer occurs and to develop ways to better treat and prevent it. To participate in this study the participant must have cancer now, had it in the past, or are at risk of developing cancer. The participant will not undergo tests or procedures that are not required as part of their routine clinical care. The investigators will ask the participant to provide an additional sample from tissue that is obtained for their clinical care including blood, bone marrow, or tissue sample. The investigators will also ask for a gentle scrape of the inside of their cheek, mouthwash or a skin sample to obtain their germline DNA
Sponsor: Dana-Farber Cancer Institute
Yes, this clinical trial (NCT02269592) has an active research site in Kalamazoo, MI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for monoclonal gammopathy of undetermined significance (mgus) treatment options in Kalamazoo, MI, this clinical trial (NCT02269592) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kalamazoo research site is actively enrolling participants for this clinical trial. You'll receive care from experienced monoclonal gammopathy of undetermined significance (mgus) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all monoclonal gammopathy of undetermined significance (mgus) clinical trials near you to find additional studies recruiting in your area.
See all multiple myeloma clinical trials recruiting in Kalamazoo — not just this study.
Browse Multiple Myeloma Trials in Kalamazoo →